H. PARLAKPINAR Et Al. , "Physiological and pharmacological concentrations of melatonin protect against doxorubucin-induced cardiotoxicty.," 1st International Meeting on Medicinal and Pharmaceutical Chemistry IMMPC-1. , Ankara, Turkey, pp.1, 2002
PARLAKPINAR, H. Et Al. 2002. Physiological and pharmacological concentrations of melatonin protect against doxorubucin-induced cardiotoxicty.. 1st International Meeting on Medicinal and Pharmaceutical Chemistry IMMPC-1. , (Ankara, Turkey), 1.
PARLAKPINAR, H., Şahna, E., Özer, M., Çiğremiş, Y., Özuğurlu, F., & Acet, A., (2002). Physiological and pharmacological concentrations of melatonin protect against doxorubucin-induced cardiotoxicty. . 1st International Meeting on Medicinal and Pharmaceutical Chemistry IMMPC-1. (pp.1). Ankara, Turkey
PARLAKPINAR, HAKAN Et Al. "Physiological and pharmacological concentrations of melatonin protect against doxorubucin-induced cardiotoxicty.," 1st International Meeting on Medicinal and Pharmaceutical Chemistry IMMPC-1., Ankara, Turkey, 2002
PARLAKPINAR, HAKAN Et Al. "Physiological and pharmacological concentrations of melatonin protect against doxorubucin-induced cardiotoxicty.." 1st International Meeting on Medicinal and Pharmaceutical Chemistry IMMPC-1. , Ankara, Turkey, pp.1, 2002
PARLAKPINAR, H. Et Al. (2002) . "Physiological and pharmacological concentrations of melatonin protect against doxorubucin-induced cardiotoxicty.." 1st International Meeting on Medicinal and Pharmaceutical Chemistry IMMPC-1. , Ankara, Turkey, p.1.
@conferencepaper{conferencepaper, author={HAKAN PARLAKPINAR Et Al. }, title={Physiological and pharmacological concentrations of melatonin protect against doxorubucin-induced cardiotoxicty.}, congress name={1st International Meeting on Medicinal and Pharmaceutical Chemistry IMMPC-1.}, city={Ankara}, country={Turkey}, year={2002}, pages={1} }